Class II · Moderate risk
alba BOTANICA sport mineral sunscreen
Incorrect Product Formulation: wrong sunscreen product in the package.
FDA Drug Recalls
185 recalls, newest first
Class II · Moderate risk
Monsel's Solution
CGMP Deviations: The manufacturer of this product recalled because they were not manufactured under current good manufacturing practices.
Class II · Moderate risk
Acetylcysteine for Injection 6 g/30 mL
CGMP Deviations
Class II · Moderate risk
Monsel's Solution
CGMP Deviations: Products not manufactured under current good manufacturing practices.
Class II · Moderate risk
MD Complete Clarifying Cleanser
GMP Deviations
Class II · Moderate risk
Naturmetic SPF 50 Sunscreen
GMP Deviations
Class II · Moderate risk
Solar Defense Sheer Sunscreen Broad Spectrum SPF50
GMP Deviations
Class II · Moderate risk
PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets
CGMP Deviations
Class II · Moderate risk
Class II · Moderate risk
Class II · Moderate risk
Loxapine Capsules
CGMP Deviations
Class II · Moderate risk
Loxapine Capsules
CGMP Deviations
Class II · Moderate risk
Amlodipine and Benazapril HCL Capsules
cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedure
Class II · Moderate risk
Amlodipine and Benazapril HCL Capsules
cGMP Deviations; cleaning process for equipment used to manufacture the specified batches was not followed according to procedure
Class III · Low risk
Class II · Moderate risk
Lupron Depot 22.5 mg 3 month Kit NDC 00074-3346-03 84 days supply
Lack of Processing Controls.
Class II · Moderate risk
Kisqali 600 Dose 63 tablet 200 mg NDC 00078-0874-63 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
OPDIVO 40 mg/4 mL SDV NDC 00003-3772-11 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Tasigna Capsules 150 mg NDC 00078-0592-87 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Zarxio 300 mcg/0.5 mL PFS NDC 14 days supply
Lack of Processing Controls.
Class II · Moderate risk
Perjeta 420 mg/14 mL SDV Vials 50242-0145-01 21 days supply
Lack of Processing Controls.
Class II · Moderate risk
Letrozole 2.5 mg tab NDC 51991-0759-33 30 days supply
Lack of Processing Controls.
Class II · Moderate risk
Ondansetron 8 mg tablet NDC 57237-0076-30 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Bendeka 25 mg/mL 4 mL MDVPF NDC 63459-0348-04 28 days supply
Lack of Processing Controls.
Class II · Moderate risk
Capecitabine 500 mg Tablet NDC 00378-2512-78 28 days supply and…
Lack of Processing Controls.